Biologics and Small Molecules in Lichen Sclerosus: A Systematic Review

Abstract

Keywords

lichen sclerosus biologics Janus kinase inhibitors treatment systemic systematic review

Get full access to this article

View all access options for this article.

References

Chamli

Souissi

Lichen Sclerosus. StatPearls Publishing, 2023.

Tran

Tan

Macri

Goldstein

SW.

Lichen sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci. 2019;15(7):1429-1439. doi:10.7150/ijbs.34613

Feig

Gribetz

Lebwohl

MG.

Chronic lichen sclerosus successfully treated with intralesional adalimumab. Br J Dermatol. 2016;174(3):687-689. doi:10.1111/bjd.14212

Zheng

Tang

Yang

Lichen sclerosus successfully treated with baricitinib plus psoralen and ultraviolet A. Dermatol Ther 2021;34(3):e14896. doi:10.1111/dth.14896

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

0.04 MB

0.02 MB

0.13 MB